Connect with us

National

LGBTQ Africans struggle to navigate US asylum process

Ricky ‘Rikki’ Nathanson fled Zimbabwe, now lives in Md.

Published

on

Ricky "Rikki" Nathanson (Washington Blade photo by Michael K. Lavers)

 

It is no secret that many LGBTQ individuals around the world live in fear of the negative implications that result from identifying outside the limits of cisgenderism and heteronormativity. For Africans living in Africa, this panic is even more pronounced as many are abused, jailed, or even murdered for simply existing as queer.

According to Global Citizen, homosexuality is still punishable by death in four countries on the African continent: Somalia, South Sudan, Mauritania, and Nigeria (in states where Sharia law applies). Only 22 out of the 54 countries on the African continent have legalized homosexuality, and South Africa is currently the only country where same-sex marriage is legally recognized by the government.

Although there has been some human rights progress for LGBTQ Africans, most recently with Angola decriminalizing same-sex sexual relationships, ill-sentiment toward queerness still runs rampant across the continent. So, many individuals are forced to leave their home countries and apply for asylum in Western countries like the U.S. and U.K., countries which, despite their queer-phobic cultures, are more accepting and safe to live in.

From Zimbabwe to Md.

Ricky “Rikki” Nathanson is a transgender activist from Zimbabwe who received asylum from the U.S. in February 2019. Before filing for asylum in the U.S., police officers had arrested her in Bulawayo, Zimbabwe, after she had used a women’s restroom in a hotel. While in custody, the police officers physically tortured her and forced her to undergo invasive medical and physical examinations.

After her release from police custody, she filed a lawsuit against Zimbabwe’s Home Affairs minister, the commissioner of the Zimbabwe Republic Police, the assistant commissioner of the Bulawayo Central Police Station and the leader of the Zimbabwe African National Union-Patriotic Front (ZANU-PF) party’s Youth League, and later won this lawsuit. However, because of the mounting threats to her life in Bulawayo, she sought safety through the U.S.’s asylum process and relocated to the East Coast.

“When I compare myself to other people and friends who have been in similar situations to mine, my asylum process was extremely quick,” Nathanson mentions when speaking of her journey toward winning asylum. “I think that the most strenuous thing for me was the actual interview; it was nerve-wracking.”

Nathanson applied for asylum in 2018 after she attended OutRight Action International’s annual summit in New York, the organization of which she is a board member. She won her case and received asylum approximately six weeks after — a fairly quick result compared to numerous other cases that can take years before a final decision is reached.

Nathanson’s involvement with OutRight Action International proved to be a tremendous advantage as it provided her with an extensive network of friends in the U.S. who were able to support her asylum-seeking process and alleviate the stresses associated with it. This is usually not the case for many queer Africans who seek asylum in the U.S.

“The people at OutRight Action International were good to me, and they helped me with a bit of financial support. So, I was able to pay for my legal fees,” says Nathanson.

In addition, Nathanson’s lawyer, Elinor Tesfamariam, who is of Ethiopian descent and specializes in asylum cases, “knew what she was doing.” Therefore, her expertise coupled with Nathanson’s compelling story, provided for an airtight case that couldn’t be contested.

In Nathanson’s words, “My story spoke for itself.”

Casa Ruby hired Nathanson shortly after she won her asylum case. She is currently the D.C. group’s director of housing services.

What does applying for asylum involve?

The asylum process is demanding. Not only does one need legal representation, but they need financial resources to pay for said legal representation and also for their upkeep and wellbeing while in the U.S. This poses a challenge as one cannot apply for employment authorization until a year after they have completed the asylum application. So, this alienates many asylum seekers from severely needed employment and leaves them financially insecure as they navigate the torrent of preventing the possibility of having to return to their home country.

For those without strong connections in the U.S., a common way of finding help, whether financial or material, is through word of mouth. Because of their popularity, organizations like AsylumWorks have become safe havens and places of provision, fulfilling many asylum seekers’ basic needs such as buying groceries, paying for rent, and purchasing gender-affirming clothes and cosmetics.

“When applying for asylum, it’s really important to have efficient knowledge of the system; knowing what to do, who to contact, how to contact them, and how the system works,” Nathanson mentions, regarding the legal aspect.

“For the process to work as smoothly as possible, you need assistance,” she adds. “You need to be able to access a lawyer who will be able to file for you because the process is very particular, and any small mistake will result in your documents being returned to you. I have a friend of mine who forgot to sign a page and after he resubmitted his documents, he has been waiting 18 months for a response.”

Because of how inconvenient the process can be, Nathanson’s hope is that the current administration will revise the asylum process, especially the time it takes to win asylum.

How asylum seekers’ needs are met

AsylumWorks is what Executive Director Joan Hodges-Wu calls “a holistic suite of wraparound services and support to help asylum seekers address unmet needs that can interfere with their ability to participate in the immigration legal process.” The organization “empowers asylum-seekers to rebuild their lives with dignity and purpose,” and provides much-needed community that helps them to feel seen and heard.

“When people think of asylum, they think of attorneys … but people forget that it is incredibly difficult to work with an immigration attorney and fully participate in the process if there are barriers impeding your ability to connect,” says Hodges-Wu.

Through Prism, an LGBTQ support group, AsylumWorks is able to help queer asylum seekers meet their basic needs so that they can adequately focus their energy into the legal immigration process.

Prism provides community for LGBTQ asylum seekers by giving them the opportunity to meet with other queer asylum seekers and forge friendships that lighten the burden of acclimating to the U.S.

“One of the problems our LGBTQ clients face is that many of them are highly distrustful, naturally, of disclosing intimate parts of their history, and their true gender, or sexual orientation,” Geoffrey Louden, Prism’s facilitator, mentions. “Or even if they’re not sure of that, coming to terms with, going into an immigration attorney and recounting their history.”

Given this, Prism hosts weekly Zoom hangouts where individuals talk about any topics that interest them. Topics can range from introspective conversations about identity to light-hearted anecdotes about love prospects.

Prism offers a safe community for LGBTQ asylum seekers to be themselves, feel affirmed, and relate to others amid queer phobia, which can be prevalent in immigrant communities. So, regardless of how tough resettling in the U.S. may become, LGBTQ asylum seekers are guaranteed some sense of warmth and comfort in this organization.

Advertisement
FUND LGBTQ JOURNALISM
SIGN UP FOR E-BLAST

Israel

A Wider Bridge to close

LGBTQ Jewish group said financial challenges prompted decision

Published

on

U.S. Rep. Debbie Wasserman Schultz (D-Fla.) speaks at the Capital Jewish Museum in D.C. on June 5, 2025, after A Wider Bridge honored her at its Pride event. A Wider Bridge has announced it will shut down. (Washington Blade photo by Michael K. Lavers)

A Wider Bridge on Friday announced it will shut down at the end of the month.

The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.

“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.

“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”

Arthur Slepian founded A Wider Bridge in 2010.

The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.

A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.  

The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.

A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.

“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”

Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.

Continue Reading

The White House

‘Trump Rx’ plan includes sharp cuts to HIV drug prices

President made announcement on Friday

Published

on

President Donald Trump during his meeting on lowering drug prices through TrumpRx. (Washington Blade photo by Joe Reberkenny)

President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.

During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.

“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”

Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”

“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.

Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.

Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.

Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.

Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.

These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”

Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.

“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”

Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.

“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.

“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.

Trump interjected, asking, “And that’s working well with HIV?”

“Yes,” O’Day replied.

“It’s a big event,” Trump said.

“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.

A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.

Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.

According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.

The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.

Continue Reading

The White House

EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine

Trans former assistant health secretary’s name changed on official portrait

Published

on

Adm. Rachel Levine (Washington Blade photo by Michael Key)

Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.

The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.

Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.

According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.

Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.

“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.

“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”

“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”

The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.

The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.

The Washington Blade reached out to HHS, but has not received any comment.

The lawsuit and four FOIA requests are below:

Continue Reading

Popular